Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Life Medical Sciences

This article was originally published in The Gray Sheet

Executive Summary

Files registration statement with the Securities and Exchange Commission for a proposed secondary offering of up to 500,000 units at $16.78 each. The units consist of two shares of common stock and one Class A warrant. Each Class A warrant, with an exercise price of $9, entitles the holder to one share of common stock and one Class B warrant (with an exercise price of $13.50 for one share). Proceeds would be used for "expenditures relating to the commercialization" of the development stage firm's Skin- Stretching device for wound closure, for which a 510(k) was filed in Dec. 1992; R&D; clinical trials of wound dressing gel technology; "working capital"; and debt repayment. The units will be offered through broker-dealers. The Princeton, New Jersey firm netted $5.4 mil. from an initial public offering completed in October 1992....

You may also be interested in...

An Oversupply Of COVID Antibody Treatments? Multiple Monoclonal Products Raise Potential For Errors

As distribution of Regeneron’s monoclonal antibody treatment for coronavirus begins, OWS officials worry about provider confusion with Lilly’s product due to differences in preparation and administration.

E.l.f. Has A Go At Twitch Crowd, Hitching Wagon To #Loserfruit

The maker of prestige-inspired cosmetics at value prices follows its TikTok viral success by teaming with Kathleen Belsten, aka Loserfruit, the second most-followed female gamer on the Amazon-owned livestreaming platform Twitch.

Quick Listen: Scrip’s Five Must-Know Things

Join us for a brief audio tour around the past week's key developments in the global biopharma industry, in this podcast version of Scrip's Five Must-Know Things.




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts